DexCom, Inc. (DXCM)
67.40
-1.03
(-1.51%)
USD |
NASDAQ |
Jan 09, 16:00
66.01
-1.39
(-2.06%)
Pre-Market: 09:09
DexCom Research and Development Expense (Annual): 545.70M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| BioLife Solutions, Inc. | 7.912M |
| Abbott Laboratories | 2.823B |
| Krystal Biotech, Inc. | 53.57M |
| Boston Scientific Corp. | 1.615B |
| Tandem Diabetes Care, Inc. | 184.17M |